ClinicalTrials.gov

See the following -

Drug And Device Studies Being Withheld Illegally

Don McCanne | Physicians for a National Health Program (PNHP) | November 4, 2013

Randomized clinical trials are a critical means of advancing medical knowledge. Clinical trials depend on the willingness of participants to expose themselves to the risks of randomization, blinding, and unproven interventions. The ethical justification for these risks is that society will eventually benefit from the knowledge gained from the trial. [...] Read More »

Researcher with Stage 4 Cancer Launches Site to Help Others Navigate Clinical Trials

Bob Tedeschi | STAT | May 17, 2017

Among patients with colon cancer, researcher Tom Marsilje has made a name for himself by helping others learn about new clinical trials. He has scoured the database ClinicalTrials.gov, circulated a weekly spreadsheet, and served as a clearinghouse for patients desperate for a chance to beat back their disease. But, for Marsilje, it has been a labor-intensive process, and it has been hard to escape a troubling reality...

Read More »

Too little research backs high-risk medical devices

Susan D. Hall | Fierce Health IT | August 12, 2015

The U.S. Food and Drug Administration's Premarket Approval pathway allows high-risk medical devices on the market with only one study to prove their safety and effectiveness, and there are a limited number of studies done post-market, according to research published in Journal of the American Medical Association. Medical device regulation in the U.S. is more rigorous than in other parts of the world, but "the difference is, in many European countries they have much better capacity to follow devices once they are in practice," senior author Joseph S. Ross, M.D., of the Yale University School of Medicine, told Reuters.

Read More »

What Clinical Trial Results? Now You Can See Who Isn’t Sharing Their Findings

Ed Silverman | STAT | November 3, 2016

The results for nearly half of all clinical trials conducted by big drug makers during the last decade have not been published, and one company — Ranbaxy Laboratories — has not published findings for any of the nearly three dozen trials conducted in the past 10 years, according to a new online tool. The tool was launched Thursday by AllTrials, a consortium of researchers and medical journals that has been pushing the pharmaceutical industry to do a better job of disclosing clinical trial data...

Read More »